Related Experiment Video
Updated: Jan 22, 2026

Assessing Specificity of Anticancer Drugs In Vitro
Published on: March 23, 2016
SUMOylation and anticancer drug resistance
1School of Basic Medical Sciences, Department of Medicine, Kunming University of Science and Technology, China.
Abstract:
Therapeutic resistance is a major obstacle in cancer treatment, often leading to recurrence and death. SUMOylation is a dynamic and reversible process of post-translational modification through a strict enzyme cascade that regulates the modification of target proteins by SUMO1-5 and SENP family proteins, which are involved in regulating protein stability, function, and localization to influence biological pathways, including cancers. SUMOylation contributes significantly to cancer drug resistance, undermining the efficacy of clinical treatment. Therefore, studying the role of SUMOylation in the development of cancer drug resistance has significant prospects. This review focuses on the important mechanistic role of SUMOylation in promoting or inhibiting cancer drug resistance and summarizes the feasibility of using SUMOylation as a therapeutic target for cancer treatment by combining SUMOylation inhibitors and anticancer drugs, which will provide new insights into overcoming cancer drug resistance and clinical cancer treatment.
Insights
SUMOylation significantly impacts cancer drug resistance. Targeting SUMOylation pathways with inhibitors offers a promising strategy to overcome therapeutic resistance and improve cancer treatment outcomes.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Therapeutic resistance is a critical challenge in cancer therapy, frequently resulting in disease recurrence and mortality.
- SUMOylation, a reversible post-translational modification process involving SUMO and SENP proteins, regulates protein function and stability, influencing cancer-related pathways.
- SUMOylation plays a crucial role in the development of cancer drug resistance, diminishing the effectiveness of current treatments.
Purpose of the Study:
- To elucidate the mechanistic role of SUMOylation in promoting or inhibiting cancer drug resistance.
- To explore the therapeutic potential of targeting SUMOylation pathways for overcoming cancer drug resistance.
- To review the feasibility of combining SUMOylation inhibitors with conventional anticancer drugs.
Main Methods:
- Literature review focusing on SUMOylation mechanisms in cancer.
- Analysis of studies investigating the link between SUMOylation and drug resistance.
- Synthesis of findings on the therapeutic targeting of SUMOylation.
Main Results:
- SUMOylation is implicated in both the promotion and inhibition of cancer drug resistance through various mechanisms.
- Targeting SUMOylation, particularly with SUMOylation inhibitors, demonstrates potential in sensitizing cancer cells to existing therapies.
- Combination therapies involving SUMOylation inhibitors and anticancer drugs show promise for enhancing treatment efficacy.
Conclusions:
- SUMOylation is a key regulator in the context of cancer drug resistance.
- Targeting SUMOylation pathways presents a viable therapeutic strategy to combat drug-resistant cancers.
- Further research into SUMOylation inhibitors and combination therapies is warranted for clinical application in cancer treatment.
Related Concept Videos
Resistivity
Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Equivalent Resistance
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Rolling Resistance
For instance, imagine a hard cylinder rolling on a comparatively soft surface. The cylinder's weight compresses the surface beneath it. As the cylinder moves, the material in front of it slows down due to...

